R. Rotem-Yehudar

Association of Insulin-like Growth Factor 1 Receptor with EHD1 and SNAP29*

R. Rotem-Yehudar, E. Galperin, M. Horowitz, 2001, The Journal of Biological Chemistry.

Disabling immune tolerance by programmed death-1 blockade with pidilizumab after autologous hematopoietic stem-cell transplantation for diffuse large B-cell lymphoma: results of an international phase II trial.

L. Gordon, M. Kaminski, J. Winter, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase 2, multicenter, safety and efficacy study of pidilizumab in patients with metastatic melanoma.

J. Fay, J. Wolchok, M. Atkins, 2014 .